← Leaderboards
Mariusz Z Ratajczak
University Of Pennsylvania
$9,429,196
Attributed
$10,135,118
Total exposure
6
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $721K · FY2005–21$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
Funding mix
By agency
NIH$10,135,118 · 6
By mechanism
R01$7,850,197 · 4
T32$1,411,845 · 1
P01$873,076 · 1
Top collaborators
- Sham S Kakar5 shared
Most similar at University Of Pennsylvania
Same institution · by research overlap
- Wenchao Song$30,516,555
- Frederic G Barr$8,847,995
- Rashmin C Savani$8,890,174
Others in their field
Top investigators on “Bone Marrow”
- Charles A Coltman · Southwest Oncology Group$141,983,231
- Mary M Horowitz · Medical College Of Wisconsin$136,789,389
- David Heimbrook · Leidos Biomedical Research, Inc.$56,049,457
- Richard L Schilsky · University Of Chicago$50,043,295
- Robert L Comis · Frontier Sci &Technology Rsch Fdn, Inc$48,148,202
- J. Mark Cline · Wake Forest University$31,844,583
Research focus
Bone MarrowBaseCxcr4 GeneCellsMolecularHematopoietic Stem CellsLigandsMediatingCell Adhesion MoleculesPlayHomingComplement ActivationStem CellsHematopoieticTraffickingEngraftmentCxcr4 ReceptorsAdhesionsHematopoiesisComplementGenerationsImmunodeficient MouseChemotherapyConditioning
Grant awards (34)
Current Trends in Stem Cell Therapies$226,871
T32 · FY2021 · HL · contact PI
Current Trends in Stem Cell Therapies$374,508
T32 · FY2020 · HL · contact PI
Novel mechanisms involving complement cascade in stem cell trafficking$346,500
R01 · FY2020 · DK · contact PI
Current Trends in Stem Cell Therapies$348,424
T32 · FY2019 · HL · contact PI
Novel mechanisms involving complement cascade in stem cell trafficking$346,500
R01 · FY2019 · DK · contact PI
Novel mechanisms involving complement cascade in stem cell trafficking$346,500
R01 · FY2018 · DK · contact PI
Current Trends in Stem Cell Therapies$333,291
T32 · FY2018 · HL · contact PI
Novel mechanisms involving complement cascade in stem cell trafficking$346,500
R01 · FY2017 · DK · contact PI
Current Trends in Stem Cell Therapies$128,751
T32 · FY2017 · HL · contact PI
BIOACTIVE LIPIDS IN STEM CELL HOMING AND MOBILIZATION$374,163
R01 · FY2016 · HL · contact PI
Novel hematopoietic effects of C5 cleavage fragment$329,034
R01 · FY2016 · DK · contact PI
BIOACTIVE LIPIDS IN STEM CELL HOMING AND MOBILIZATION$368,549
R01 · FY2015 · HL · contact PI
Novel hematopoietic effects of C5 cleavage fragment$329,034
R01 · FY2015 · DK · contact PI
BIOACTIVE LIPIDS IN STEM CELL HOMING AND MOBILIZATION$366,679
R01 · FY2014 · HL · contact PI
Novel hematopoietic effects of C5 cleavage fragment$329,034
R01 · FY2014 · DK · contact PI
BIOACTIVE LIPIDS IN STEM CELL HOMING AND MOBILIZATION$368,103
R01 · FY2013 · HL · contact PI
Novel hematopoietic effects of C5 cleavage fragment$341,534
R01 · FY2013 · DK · contact PI
Novel hematopoietic effects of C3 cleavage fragments$275,428
R01 · FY2011 · DK · contact PI
Novel hematopoietic effects of C3 cleavage fragments$278,210
R01 · FY2010 · DK · contact PI
Novel hematopoietic effects of C3 cleavage fragments$281,021
R01 · FY2009 · DK · contact PI
The CXCR4-SDF-1 Axis in Metastatic Rhabdomyosarcoma$257,678
R01 · FY2009 · CA · contact PI
Novel hematopoietic effects of C3 cleavage fragments$281,021
R01 · FY2008 · DK · contact PI
The CXCR4-SDF-1 Axis in Metastatic Rhabdomyosarcoma$257,678
R01 · FY2008 · CA · contact PI
Novel hematopoietic effects of C3 cleavage fragments$296,596
R01 · FY2007 · DK · contact PI
The CXCR4-SDF-1 Axis in Metastatic Rhabdomyosarcoma$257,678
R01 · FY2007 · CA · contact PI
The CXCR4-SDF-1 Axis in Metastatic Rhabdomyosarcoma$265,374
R01 · FY2006 · CA · contact PI
The CXCR4-SDF-1 Axis in Metastatic Rhabdomyosarcoma$281,043
R01 · FY2005 · CA
CORE--MURINE AND HUMAN STEM CELL$348,824
P01 · FY2002 · DK
CELLULAR AND MOLECULAR BASIS OF HIV BASED THROMBOCYTOPEN$324,820
R01 · FY2002 · HL
CELLULAR AND MOLECULAR BASIS OF HIV BASED THROMBOCYTOPEN$71,500
R01 · FY2002 · HL
CORE--MURINE AND HUMAN STEM CELL$348,824
P01 · FY2001 · DK
CELLULAR AND MOLECULAR BASIS OF HIV BASED THROMBOCYTOPEN$253,320
R01 · FY2001 · HL
CELLULAR AND MOLECULAR BASIS OF HIV BASED THROMBOCYTOPEN$276,700
R01 · FY2000 · HL
CORE--MURINE AND HUMAN STEM CELL$175,428
P01 · FY2000 · DK